Keyword: Roche

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...


Roche Launches Genomic Profiling Kit for Cancer Analysis

29.10.2021 -

Swiss drugmaker Roche has launched a genomic profiling kit that it has developed in conjunction with Foundation Medicine. The Basel-based company is supplying the kit...


Roche Acquires Irish Biotech Inflazome

05.10.2020 -

Swiss drugmaker Roche has acquired Irish biotech Inflazome for €380 million, said to be one of the largest deals in Irish biotech history. Headquartered in Dublin...


Celleron Takes Roche Cancer Drug

21.08.2020 -

UK biopharma Celleron Therapeutics has signed a licensing deal with Roche, gaining exclusive worldwide rights to the Swiss pharma’s monoclonal antibody emactuzumab, which...


Roche in Cancer and Immunology Collaborations

24.07.2020 -

Roche has announced two separate collaborations, one for an investigational cancer treatment and the other for the discovery of small molecule drugs for treating immune...


Pierre-Alain Ruffieux new CEO of Lonza

09.06.2020 - Pierre-Alain Ruffieux has been appointed CEO of Swiss CDMO Lonza, with effect from 1 November 2020. The new chief executive will succeed Marc Funk, who led the company from March...


Roche Links with Vividion on E3 Ligases

22.05.2020 - Roche has signed a worldwide option and license agreement with Vividion Therapeutics, gaining access to the latter’s proteomics screening platform and proprietary small molecule...


Roche and Arrakis Link on RNA-targeted Drugs

15.04.2020 - Swiss drugmaker Roche has entered into a strategic collaboration and license agreement with US biopharma Arrakis Therapeutics for the discovery of RNA-targeted small molecule (rSM)...